• -
  • English
  • Japanese
  • Korean
表紙
市場調查報告書
商品編碼
781815

全球主要國家的過敏性結膜炎市場:SAC、PAC、VKC、AKC、GPC

Global Allergic Conjunctivitis Market, Patients, Treated Patients, by Countries (India, China, Japan, US, UK, etc), Disease Type(SAC, PAC, VKC, AKC, GPC), Drugs Profile (Zerviate, OTX-DP, ADX-102, PRT-2761, etc) Companies, Growth Drivers & Challenges
出版日期: | 出版商: Renub Research | 英文 127 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球過敏性結膜炎的市場預測至2025年將成長到超過20億美元的規模。

本報告提供全球過敏性結膜炎的市場調查，疾病概要，市場規模及患者數、治療中的患者數的變化與預測，各疾病種類的市場佔有率，各主要國家的詳細分析，已上市藥、開發平台藥物的簡介，市場成長的各種影響因素分析，主要企業的簡介、配合措施等資料彙整。

第1章 摘要整理

第2章 過敏性結膜炎:全球市場規模、患者數

  • 過敏性結膜炎市場
  • 患者數
  • 治療中的患者數

第3章 過敏性結膜炎市場:市場佔有率的變化、預測

  • 各國佔有率
  • 患者人口的佔有率
  • 治療中的患者數的佔有率
  • 各疾病類型佔有率

第4章 印度

  • 患者數
  • 治療中的患者數
  • 過敏性結膜炎市場

第5章 中國

  • 患者數
  • 治療中的患者數
  • 過敏性結膜炎市場

第6章 日本

  • 患者數
  • 治療中的患者數
  • 過敏性結膜炎市場

第7章 美國

  • 患者數
  • 治療中的患者數
  • 過敏性結膜炎市場

第8章 英國

  • 患者數
  • 治療中的患者數
  • 過敏性結膜炎市場

第9章 法國

  • 患者數
  • 治療中的患者數
  • 過敏性結膜炎市場

第10章 德國

  • 患者數
  • 治療中的患者數
  • 過敏性結膜炎市場

第11章 義大利

  • 患者數
  • 治療中的患者數
  • 過敏性結膜炎市場

第12章 西班牙

  • 患者數
  • 治療中的患者數
  • 過敏性結膜炎市場

第13章 全球過敏性結膜炎市場:各疾病類型

  • 季節性過敏性結膜炎 (SAC)、全年性過敏性結膜炎 (PAC)
  • 春季粘膜炎 (VKC)
  • 特異反應性性角結膜炎 (AKC)
  • 巨大乳頭結膜炎 (GPC)

第14章 已上市藥、開發平台藥物的簡介

  • Zerviate
  • OTX-DP (Dexamethasone Insert)
  • ADX-102
  • PRT2761
  • CVXL-0074
  • AK-002
  • Bertilimumab
  • Reproxalap
  • ST-266
  • SYL-116011

第15章 成長推動因素

第16章 課題

第17章 Santen Pharmaceutical

  • 企業概要
  • 舉措、配合措施
  • 財務分析

第18章 Alcon Inc. (Novartis)

  • 企業概要
  • 舉措、配合措施
  • 財務分析

第19章 Portola Pharmaceuticals Inc.

  • 企業概要
  • 舉措、配合措施
  • 財務分析

第20章 Ocular Therapeutix Inc.

  • 企業概要
  • 舉措、配合措施
  • 財務分析
目錄

Allergic conjunctivitis is a kind of eye disease in which it affect the eye surfaces and are commonly associated to immune-mediated inflammatory reactions of these structures. The prevalence of the allergic conjunctivitis is found more in summer and spring across the various regions. Pollen, dust, irritants such as cigarette smoke, perfumes etc. are some of the substance that triggers the conjunctivitis. Itching is the most typical sign of allergic conjunctivitis, and more than 75 percent of patients report this symptom when seeking treatment. According to Renub Research Allergic Conjunctivitis Market is expected to be more than USD 2 Billion market by 2025.

Global allergic conjunctivitis market will grow due to increasing prevalence of various allergic conjunctivitis, development in medical infrastructure in the developing countries, growing awareness about allergic conjunctivitis among people, increasing ageing population and upcoming therapies such as Zerviate, ADX-102, PRT-2761, OTX-DP etc. Allergic conjunctivitis are classified mainly in five types: Seasonal Allergic Conjunctivitis (SAC), Perennial Allergic Conjunctivitis (PAC), Vernal Keratoconjunctivitis (VKC), Atopic Keratoconjunctivitis (AKC) and Giant Papillary Conjunctivitis (GPC).

Renub Research report titled "Global Allergic Conjunctivitis Market, Patients, Treated Patients By Countries (India, China, Japan, United States, United Kingdom, France, Germany, Italy, Spain), Disease Type (Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC), Vernal Keratoconjunctivitis (VKC), Atopic Keratoconjunctivitis (AKC) And Giant Papillary Conjunctivitis (GPC)), Drugs Profile (Zerviate, OTX-DP, ADX-102, PRT-2761, CVXL-0074, AK-002, Bertilimumab, Reproxalap, ST-266, SYL-116011) Companies (Santen Pharmaceutical, Alcon (Novartis), Portola Pharmaceuticals, Ocular Therapeutix), Growth Drivers, Challenges" provides a complete analysis of global allergic conjunctivitis market.

China Dominates the Global Allergic Conjunctivitis Patient Population

In this report, we have shown complete insight of country analysis of allergic conjunctivitis patient population. The covered countries are; India, China, Japan, United States, United Kingdom, France, Germany, Italy and Spain. China dominates the global allergic conjunctivitis patient population numbers.

United States is the leading Country in the Global Allergic Conjunctivitis Market

Allergic conjunctivitis market is growing across all parts of the world. Market growth rates varies in the countries covered in the report India, China, Japan, United States, United Kingdom, France, Germany, Italy and Spain. United States is leading country in the global allergic conjunctivitis market due to growing awareness, strong healthcare support system and large patient population.

Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC) Hold Majority of Market in the Global Allergic Conjunctivitis Market

On the basis of disease type, global Allergic conjunctivitis market is further segmented into seasonal allergic conjunctivitis (SAC) & perennial allergic conjunctivitis (PAC) market, vernal keratoconjunctivitis (VKC) market, atopic keratoconjunctivitis (AKC) market and giant papillary conjunctivitis (GPC) market, globally. Seasonal allergic conjunctivitis (SAC) & perennial allergic conjunctivitis (PAC) hold majority of market share in the global allergic conjunctivitis market.

Allergic Conjunctivitis Pipe Line Drugs are Key Strength for this Market Place

In the global allergic conjunctivitis market, allergic conjunctivitis pipe line drugs will play the major role for the growth of this market. At present several drugs such as Zerviate, OTX-DP, ADX-102, PRT-2761, CVXL-0074, AK-002, Bertilimumab, Reproxalap, ST-266, SYL-116011 etc. are in preclinical, IND, Phase I, Phase II and Phase III stage.

Report has been analyzed from 9 Major Viewpoints:

  • 1. Global Allergic Conjunctivitis Market
  • 2. Global Allergic Conjunctivitis Market Share, Disease Type Market Share, Patients Share, Treated Patients Share
  • 3. Country Allergic Conjunctivitis Market
  • 4. Country Allergic Conjunctivitis Patients Population
  • 5. Country Allergic Conjunctivitis Treated Patients Population
  • 6. Disease Type Allergic Conjunctivitis Market
  • 7. Allergic Conjunctivitis Drugs Pipeline
  • 8. Growth Drivers and Challenges
  • 9. Key Allergic Conjunctivitis Companies Initiatives and Financial Insight

Country Covered - Global Allergic Conjunctivitis Market

  • India
  • China
  • Japan
  • United States
  • United Kingdom
  • France
  • Germany
  • Italy
  • Spain

Disease Type Covered - Global Allergic Conjunctivitis Market

  • Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC)
  • Vernal Keratoconjunctivitis (VKC)
  • Atopic Keratoconjunctivitis (AKC)
  • Giant Papillary Conjunctivitis (GPC)

Drugs Profile Covered - Global Allergic Conjunctivitis Market

  • Zerviate
  • OTX-DP
  • ADX-102
  • PRT-2761
  • CVXL-0074
  • AK-002
  • Bertilimumab
  • Reproxalap
  • ST-266
  • SYL-116011

Company Covered

  • Santen Pharmaceutical
  • Alcon (Novartis)
  • Portola Pharmaceuticals
  • Ocular Therapeutix

Table of Contents

1. Executive Summary

2. Global Allergic Conjunctivitis Market and Patients Analysis

  • 2.1 Allergic Conjunctivitis Market
  • 2.2 Allergic Conjunctivitis Patient Numbers
  • 2.3 Allergic Conjunctivitis Treated Patient Numbers

3. Share Analysis - Global Allergic Conjunctivitis

  • 3.1 Country Market Share
  • 3.2 Patients Population Share
  • 3.3 Treated Patients Population Share
  • 3.4 By Disease Type Share

4. India

  • 4.1 Allergic Conjunctivitis Patient Numbers
  • 4.2 Allergic Conjunctivitis Treated Patient Numbers
  • 4.3 Allergic Conjunctivitis Market

5. China

  • 5.1 Allergic Conjunctivitis Patient Numbers
  • 5.2 Allergic Conjunctivitis Treated Patient Numbers
  • 5.3 Allergic Conjunctivitis Market

6. Japan

  • 6.1 Allergic Conjunctivitis Patient Numbers
  • 6.2 Allergic Conjunctivitis Treated Patient Numbers
  • 6.3 Allergic Conjunctivitis Market

7. United States

  • 7.1 Allergic Conjunctivitis Patient Numbers
  • 7.2 Allergic Conjunctivitis Treated Patient Numbers
  • 7.3 Allergic Conjunctivitis Market

8. United Kingdom

  • 8.1 Allergic Conjunctivitis Patient Numbers
  • 8.2 Allergic Conjunctivitis Treated Patient Numbers
  • 8.3 Allergic Conjunctivitis Market

9. France

  • 9.1 Allergic Conjunctivitis Patient Numbers
  • 9.2 Allergic Conjunctivitis Treated Patient Numbers
  • 9.3 Allergic Conjunctivitis Market

10. Germany

  • 10.1 Allergic Conjunctivitis Patient Numbers
  • 10.2 Allergic Conjunctivitis Treated Patient Numbers
  • 10.3 Allergic Conjunctivitis Market

11. Italy

  • 11.1 Allergic Conjunctivitis Patient Numbers
  • 11.2 Allergic Conjunctivitis Treated Patient Numbers
  • 11.3 Allergic Conjunctivitis Market

12. Spain

  • 12.1 Allergic Conjunctivitis Patient Numbers
  • 12.2 Allergic Conjunctivitis Treated Patient Numbers
  • 12.3 Allergic Conjunctivitis Market

13. Disease Type - Global Allergic Conjunctivitis Market

  • 13.1 Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC)
  • 13.2 Vernal Keratoconjunctivitis (VKC)
  • 13.3 Atopic Keratoconjunctivitis (AKC)
  • 13.4 Giant Papillary Conjunctivitis (GPC)

14. Global Allergic Conjunctivitis Drugs Profile/Pipe Line Drugs

  • 14.1 Zerviate
  • 14.2 OTX-DP (Dexamethasone Insert)
  • 14.3 ADX-102
  • 14.4 PRT2761
  • 14.5 CVXL-0074
  • 14.6 AK-002
  • 14.7 Bertilimumab
  • 14.8 Reproxalap
  • 14.9 ST-266
  • 14.10 SYL-116011

15. Growth Driver

  • 15.1 Rapid Urbanization and Growth of Particulate Pollution
  • 15.2 Increasing Ageing Population & Widespread Use of Medications for Various Eye Diseases

16. Challenges

  • 16.1 Diagnostic Challenges
  • 16.2 Undertreated by Patients

17. Santen Pharmaceutical

  • 17.1 Company Overview
  • 17.2 Initiatives
    • 17.2.1 Point 1
    • 17.2.2 Point 2
  • 17.3 Financial Insight

18. Alcon Inc. (Novartis)

  • 18.1 Company Overview
  • 18.2 Initiatives
    • 18.2.1 Point 1
    • 18.2.2 Point 2
  • 18.3 Financial Insight

19. Portola Pharmaceuticals Inc.

  • 19.1 Company Overview
  • 19.2 Initiatives
    • 19.2.1 Point 1
    • 19.2.2 Point 2
  • 19.3 Financial Insight

20. Ocular Therapeutix Inc.

  • 20.1 Company Overview
  • 20.2 Initiatives
    • 20.2.1 Point 1
    • 20.2.2 Point 2
  • 20.3 Financial Insight

List of Figures:

Figure 2 1: Global - Allergic Conjunctivitis Market (Million US$), 2013 - 2018

Figure 2 2: Global - Forecast for Allergic Conjunctivitis Market (Million US$), 2019 - 2025

Figure 2 3: Global - Allergic Conjunctivitis Patient Numbers (Million), 2013 - 2018

Figure 2 4: Global - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 - 2025

Figure 2 5: Global - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 - 2018

Figure 2 6: Global - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 - 2025

Figure 3 1: Global - Allergic Conjunctivitis Market Country Share (Percent), 2013 - 2018

Figure 3 2: Global - Forecast for Allergic Conjunctivitis Market Country Share (Percent), 2019 - 2025

Figure 3 3: Global - Allergic Conjunctivitis Treated Patients Population Country Share (Percent), 2013 - 2018

Figure 3 4: Global - Forecast for Allergic Conjunctivitis Treated Patients Population Country Share (Percent), 2019 - 2025

Figure 3 5: Global - Allergic Conjunctivitis Disease Type Market Share (Percent), 2013 - 2018

Figure 3 6: Global - Forecast for Allergic Conjunctivitis Disease Type Market Share (Percent), 2019 - 2025

Figure 4 1: India - Allergic Conjunctivitis Patient Numbers (Million), 2013 - 2018

Figure 4 2: India - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 - 2025

Figure 4 3: India - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 - 2018

Figure 4 4: India - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 - 2025

Figure 4 5: India - Allergic Conjunctivitis Market (Million US$), 2013 - 2018

Figure 4 6: India - Forecast for Allergic Conjunctivitis Market (Million US$), 2019 - 2025

Figure 5 1: China - Allergic Conjunctivitis Patient Numbers (Million), 2013 - 2018

Figure 5 2: China - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 - 2025

Figure 5 3: China - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 - 2018

Figure 5 4: China - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 - 2025

Figure 5 5: China - Allergic Conjunctivitis Market (Million US$), 2013 - 2018

Figure 5 6: China - Forecast for Allergic Conjunctivitis Market (Million US$), 2019 - 2025

Figure 6 1: Japan - Allergic Conjunctivitis Patient Numbers (Million), 2013 - 2018

Figure 6 2: Japan - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 - 2025

Figure 6 3: Japan - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 - 2018

Figure 6 4: Japan - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 - 2025

Figure 6 5: Japan - Allergic Conjunctivitis Market (Million US$), 2013 - 2018

Figure 6 6: Japan - Forecast for Allergic Conjunctivitis Market (Million US$), 2019 - 2025

Figure 7 1: United States - Allergic Conjunctivitis Patient Numbers (Million), 2013 - 2018

Figure 7 2: United States - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 - 2025

Figure 7 3: United States - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 - 2018

Figure 7 4: United States - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 - 2025

Figure 7 5: United States - Allergic Conjunctivitis Market (Million US$), 2013 - 2018

Figure 7 6: United States - Forecast for Allergic Conjunctivitis Market (Million US$), 2019 - 2025

Figure 8 1: United Kingdom - Allergic Conjunctivitis Patient Numbers (Million), 2013 - 2018

Figure 8 2: United Kingdom - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 - 2025

Figure 8 3: United Kingdom - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 - 2018

Figure 8 4: United Kingdom - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 - 2025

Figure 8 5: United Kingdom - Allergic Conjunctivitis Market (Million US$), 2013 - 2018

Figure 8 6: United Kingdom - Forecast for Allergic Conjunctivitis Market (Million US$), 2019 - 2025

Figure 9 1: France - Allergic Conjunctivitis Patient Numbers (Million), 2013 - 2018

Figure 9 2: France - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 - 2025

Figure 9 3: France - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 - 2018

Figure 9 4: France - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 - 2025

Figure 9 5: France - Allergic Conjunctivitis Market (Million US$), 2013 - 2018

Figure 9 6: France - Forecast for Allergic Conjunctivitis Market (Million US$), 2019 - 2025

Figure 10 1: Germany - Allergic Conjunctivitis Patient Numbers (Million), 2013 - 2018

Figure 10 2: Germany - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 - 2025

Figure 10 3: Germany - Allergic Conjunctivitis Patient Treated Numbers (Million), 2013 - 2018

Figure 10 4: Germany - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 - 2025

Figure 10 5: Germany - Allergic Conjunctivitis Market (Million US$), 2013 - 2018

Figure 10 6: Germany - Forecast for Allergic Conjunctivitis Market (Million US$), 2019 - 2025

Figure 11 1: Italy - Allergic Conjunctivitis Patient Numbers (Million), 2013 - 2018

Figure 11 2: Italy - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 - 2025

Figure 11 3: Italy - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 - 2018

Figure 11 4: Italy - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 - 2025

Figure 11 5: Italy - Allergic Conjunctivitis Market (Million US$), 2013 - 2018

Figure 11 6: Italy - Forecast for Allergic Conjunctivitis Market (Million US$), 2019 - 2025

Figure 12 1: Spain - Allergic Conjunctivitis Patient Numbers (Million), 2013 - 2018

Figure 12 2: Spain - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 - 2025

Figure 12 3: Spain - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 - 2018

Figure 12 4: Spain - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 - 2025

Figure 12 5: Spain - Allergic Conjunctivitis Market (Million US$), 2013 - 2018

Figure 12 6: Spain - Forecast for Allergic Conjunctivitis Market (Million US$), 2019 - 2025

Figure 13 1: Global - Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC) Market (Million US$), 2013 - 2018

Figure 13 2: Global - Forecast for Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC) Market (Million US$), 2019 - 2025

Figure 13 3: Global - Vernal Keratoconjunctivitis (VKC) Market (Million US$), 2013 - 2018

Figure 13 4: Global - Forecast for Vernal Keratoconjunctivitis (VKC) Market (Million US$), 2019 - 2025

Figure 13 5: Global - Atopic Keratoconjunctivitis (AKC) Market (Million US$), 2013 - 2018

Figure 13 6: Global - Forecast for Atopic Keratoconjunctivitis (AKC) Market (Million US$), 2019 - 2025

Figure 13 7: Global - Giant Papillary Conjunctivitis (GPC) Market (Million US$), 2013 - 2018

Figure 13 8: Global - Forecast for Giant Papillary Conjunctivitis (GPC) Market (Million US$), 2019 - 2025

Figure 14 1: Allergic Conjunctivitis Pipe Line Drug - Zerviate Status (2018)

Figure 14 2: Allergic Conjunctivitis Pipe Line Drug - OTX-DP (Dexamethasone Insert) Status (2018)

Figure 14 3: Allergic Conjunctivitis Pipe Line Drug - ADX-102 Status (2018)

Figure 14 4: Allergic Conjunctivitis Pipe Line Drug - PRT-2761Status (2018)

Figure 14 5: Allergic Conjunctivitis Pipe Line Drug - CVXL-0074 Status (2018)

Figure 14 6: Allergic Conjunctivitis Pipe Line Drug - AK-002 Status (2018)

Figure 14 7: Allergic Conjunctivitis Pipe Line Drug - Bertilimumab Status (2018)

Figure 14 8: Allergic Conjunctivitis Pipe Line Drug - Reproxalap Status (2018)

Figure 14 9: Allergic Conjunctivitis Pipe Line Drug - ST-266 Status (2018)

Figure 14 10: Allergic Conjunctivitis Pipe Line Drug - SYL-116011 Status (2018)

Figure 17 1: Santen Pharmaceutical - Global Revenue (Million US$), 2014 - 2018

Figure 17 2: Santen Pharmaceutical - Forecast for Global Revenue (Million US$), 2019 - 2025

Figure 18 1: Alcon (Novartis) - Global Revenue (Million US$), 2014 - 2018

Figure 18 2: Alcon (Novartis) - Forecast for Global Revenue (Million US$), 2019 - 2025

Figure 19 1: Portola Pharmaceuticals - Global Revenue (Thousand US$), 2014 - 2018

Figure 19 2: Portola Pharmaceuticals - Forecast for Global Revenue (Thousand US$), 2019 - 2025

Figure 20 1: Ocular Therapeutix - Global Revenue (Thousand US$), 2014 - 2018

Figure 20 2: Ocular Therapeutix - Forecast for Global Revenue (Thousand US$), 2019 - 2025

List of Tables:

Table 3 1: Global - Allergic Conjunctivitis Patients Population Country Share (Percent), 2013 - 2018

Table 3 2: Global - Forecast for Allergic Conjunctivitis Patients Population Country Share (Percent), 2019 - 2025